Literature DB >> 29027057

Comparative analysis of mean retinal thickness measured using SD-OCT in normal young or old age and glaucomatous eyes.

Jun Won Jang1, Myung Won Lee2, Kyong Jin Cho3.   

Abstract

PURPOSE: To evaluate changes in macular thickness, ganglion cell layer/inner plexiform layer (GCL/IPL) thickness, and retinal nerve fiber layer (RNFL) thickness in normal eyes and glaucomatous eyes using spectral domain optical coherence tomography (SD-OCT).
METHODS: We enrolled 89 eyes (all left eyes), including 45 (of 45 patients) eyes with glaucoma and 44 (of 44 patients) normal eyes. The data from macular measurements using spectral domain optical coherence tomography were analyzed according to groups divided by age and glaucoma status. The macular thickness analysis, GCL/IPL thickness, and RNFL thickness values determined by SD-OCT scans were compared among the groups.
RESULTS: Mean macular thickness decreased significantly with age or glaucoma. Mean GCL/IPL thickness decreased significantly in glaucomatous eyes in all sectors but did not decrease with age. Mean RNFL thickness, which was divided into four quadrants (superior, nasal, inferior, and temporal), decreased significantly in glaucomatous eyes at all quadrants and decreased in the temporal quadrant with age in non-glaucomatous eyes. No significant differences were detected between eyes with normal tension glaucoma (NTG) and primary open angle glaucoma (POAG) in all sectors of mean GCL/IPL thickness, RNFL thickness, and macular thickness.
CONCLUSIONS: No significant difference in mean thickness was detected between eyes with NTG and POAG. Some of the sectors of RNFL thickness decreased with age or glaucoma. GCL/IPL thickness, however, decreased in glaucomatous eyes but not with age. Therefore, GCL/IPL thickness is less influenced by age when monitoring patients with glaucoma or suspect glaucoma.

Entities:  

Keywords:  GCL/IPL thickness; Macular thickness; NTG; POAG; RNFL thickness

Mesh:

Year:  2017        PMID: 29027057     DOI: 10.1007/s10792-017-0744-7

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  29 in total

1.  Three-dimensional imaging of macular inner structures in glaucoma by using spectral-domain optical coherence tomography.

Authors:  Yuriko Kotera; Masanori Hangai; Fumitaka Hirose; Satoshi Mori; Nagahisa Yoshimura
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-14       Impact factor: 4.799

2.  Macular ganglion cell layer imaging in preperimetric glaucoma with speckle noise-reduced spectral domain optical coherence tomography.

Authors:  Noriko Nakano; Masanori Hangai; Hideo Nakanishi; Satoshi Mori; Masayuki Nukada; Yuriko Kotera; Hanako Ohashi Ikeda; Hajime Nakamura; Atsushi Nonaka; Nagahisa Yoshimura
Journal:  Ophthalmology       Date:  2011-09-15       Impact factor: 12.079

3.  Quantification of nerve fiber layer thickness in normal and glaucomatous eyes using optical coherence tomography.

Authors:  J S Schuman; M R Hee; C A Puliafito; C Wong; T Pedut-Kloizman; C P Lin; E Hertzmark; J A Izatt; E A Swanson; J G Fujimoto
Journal:  Arch Ophthalmol       Date:  1995-05

4.  Macular ganglion cell/inner plexiform layer measurements by spectral domain optical coherence tomography for detection of early glaucoma and comparison to retinal nerve fiber layer measurements.

Authors:  Kouros Nouri-Mahdavi; Sara Nowroozizadeh; Nariman Nassiri; Nila Cirineo; Shane Knipping; Joann Giaconi; Joseph Caprioli
Journal:  Am J Ophthalmol       Date:  2013-09-25       Impact factor: 5.258

5.  Analysis of normal retinal nerve fiber layer thickness by age, sex, and race using spectral domain optical coherence tomography.

Authors:  Tarek Alasil; Kaidi Wang; Pearse A Keane; Hang Lee; Neda Baniasadi; Johannes F de Boer; Teresa C Chen
Journal:  J Glaucoma       Date:  2013-09       Impact factor: 2.503

6.  Heidelberg retina tomography and optical coherence tomography in normal, ocular-hypertensive, and glaucomatous eyes.

Authors:  A Mistlberger; J M Liebmann; D S Greenfield; M E Pons; S T Hoh; H Ishikawa; R Ritch
Journal:  Ophthalmology       Date:  1999-10       Impact factor: 12.079

7.  Change in the optic disc and nerve fiber layer estimated with the glaucoma-scope in monkey eyes.

Authors:  H A Quigley; M E Pease
Journal:  J Glaucoma       Date:  1996-04       Impact factor: 2.503

8.  Macular thickness measurements in normal eyes using spectral domain optical coherence tomography.

Authors:  John E Legarreta; Giovanni Gregori; Omar S Punjabi; Robert W Knighton; Geeta A Lalwani; Carmen A Puliafito
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2008 Jul-Aug

Review 9.  The pathophysiology and treatment of glaucoma: a review.

Authors:  Robert N Weinreb; Tin Aung; Felipe A Medeiros
Journal:  JAMA       Date:  2014-05-14       Impact factor: 56.272

10.  Detection of macular ganglion cell loss in glaucoma by Fourier-domain optical coherence tomography.

Authors:  Ou Tan; Vikas Chopra; Ake Tzu-Hui Lu; Joel S Schuman; Hiroshi Ishikawa; Gadi Wollstein; Rohit Varma; David Huang
Journal:  Ophthalmology       Date:  2009-09-10       Impact factor: 12.079

View more
  3 in total

Review 1.  Macular imaging with optical coherence tomography in glaucoma.

Authors:  Vahid Mohammadzadeh; Nima Fatehi; Adeleh Yarmohammadi; Ji Woong Lee; Farideh Sharifipour; Ramin Daneshvar; Joseph Caprioli; Kouros Nouri-Mahdavi
Journal:  Surv Ophthalmol       Date:  2020-03-19       Impact factor: 6.048

2.  The Relationship Between Retinal Nerve Fiber Layer Thickness and Clinical Symptoms of Alzheimer's Disease.

Authors:  Teng-Hong Lian; Zhao Jin; Yuan-Zhen Qu; Peng Guo; Hui-Ying Guan; Wei-Jiao Zhang; Du-Yu Ding; Da-Ning Li; Li-Xia Li; Xiao-Min Wang; Wei Zhang
Journal:  Front Aging Neurosci       Date:  2021-01-29       Impact factor: 5.750

3.  Effectiveness of Glaucoma Diagnostic Parameters from Spectral Domain-Optical Coherence Tomography of Myopic Patients.

Authors:  Yuan Fang; Han-Qiao Zhang; Rong-Hua Qiao; Xu-Yang Yao; Ying-Zi Pan; Mei Li
Journal:  Chin Med J (Engl)       Date:  2018-08-05       Impact factor: 2.628

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.